Clinical Data Abstract Presentation; IP Portfolio of 9 Patents; Phase 3 Cancer Treatments: RenovoRx NASDAQ: RNXT $RNXT
RenovoRx (NASDAQ: RNXT) Shaping the Future: Clinical Data Abstract Presentation and Robust IP Portfolio Enhance Cancer Treatment Capabilities RenovoRx, Inc. (NASDAQ:RNXT) LOS ALTOS, CALIFORNIA, UNITED STATES, December 21, 2023 /EINPresswire.com/ -- …